GlassScriptPhysician profile
Scott Bradley
NPI 1548571771
$3,853.33
in general payments reported to CMS, 2019-2025
27 companies · $324 in 2025
The $324 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $585 · 2020: $220 · 2021: $904 · 2022: $758 · 2023: $433 · 2024: $629 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,386.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,060.29 | 2019-2025 | Evenity, Prolia, Prolia |
| Collegium Pharmaceutical, INC. | $349.94 | 2022-2025 | Xtampza, Belbuca |
| Bioventus LLC | $325.67 | 2019-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Pacira Therapeutics, INC. | $318.34 | 2019-2021 | |
| Si-Bone, INC. | $316.90 | 2019-2021 | |
| Nevro Corp. | $223.16 | 2019-2024 | Senza |
| Ferring Pharmaceuticals INC. | $176.44 | 2019-2024 | Euflexxa |
| Fidia Pharma USA INC. | $143.94 | 2019-2023 | Hymovis |
| Kowa Pharmaceuticals America, INC. | $130.84 | 2022-2023 | Seglentis |
| Boston Scientific Corporation | $94.51 | 2021-2025 | Wavewriter Alpha Prime 16 |
| Fortis Surgical, LLC | $91.83 | 2024 | |
| Abbott Laboratories | $88.23 | 2019-2025 | Proclaim |
| Medtronic, INC. | $80.83 | 2025 | Intellis Adaptivestim |
| Electronic Waveform Lab, INC. | $65.85 | 2021-2022 | |
| Curonix LLC | $53.75 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $46.51 | 2020-2022 | |
| Spr Therapeutics, INC | $44.81 | 2025 | Sprint Pns System |
| Heron Therapeutics, INC. | $40.07 | 2021 | |
| Biodelivery Sciences International, INC. | $37.75 | 2020-2021 | |
| Painteq LLC | $35.70 | 2024 | Painteq |
| Avanos Medical | $29.56 | 2021-2023 | Coolief* Cooled Radiofrequency |
| Pacira Pharmaceuticals Incorporated | $22.28 | 2019 | |
| Vericel Corporation | $20.91 | 2025 | Maci |
| Allergan, INC. | $15.54 | 2021 | |
| Globus Medical, INC. | $15.33 | 2025 | Senza |
| Pfizer INC. | $12.76 | 2019 | |
| Horizon Therapeutics Plc | $11.59 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Bradley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.